Richard H. Creech - Concepedia

Author

Richard H. Creech

Dana-Farber Cancer Institute

Also Known As

R Creech, R H Creech, R. Creech, Richard Creech, Richard H Creech, Richard H. Creech

Publications

13.8K

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Fox Chase Cancer Center University of Wisconsin Carbone Cancer Center University of Pennsylvania Albany Medical Center Hospital

About

Richard H. Creech is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	24	12.9K
2	Health Sciences	12	12	12.2K
3	Head And Neck Surgery	1	1	20
4	Hepatology	1	1	86
5	Immunology	1	1	23

Richard H. Creech

Publications

13.7K

Citations

H-Index

Page 1

	Year	Citations
Toxicity and response criteria of the Eastern Cooperative Oncology Group Martin M. Oken, Richard H. Creech, Douglass C. Tormey, American Journal of Clinical Oncology Health SciencesMedicineCancer ManagementClinical EndpointPharmacology	1982	11.4K
A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma Katsutaro Shimaoka, David Schoenfeld, William D. DeWys, Cancer	1985	461
A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer. John C. Ruckdeschel, Dianne M. Finkelstein, David S. Ettinger, Journal of Clinical Oncology MedicineChemotherapyMetronomic TherapyClinical TrialsMetastatic Nsclc	1986	343
Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas. Ernest C. Borden, David A. Amato, Charles Rosenbaum, Journal of Clinical Oncology Surgical OncologySoft Tissue SarcomaMedicineDtic 250Pharmacology	1987	292
Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V--a randomized comparison of four cisplatin-containing regimens. John C. Ruckdeschel, Dianne M. Finkelstein, Bernard A. Mason, Journal of Clinical Oncology Generation VPharmacotherapyMetronomic ChemotherapyGeneration IiOncology	1985	108
A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma: An ECOG study G Falkson, Louise Ryan, Lewis A. Johnson, Cancer Cancer ManagementPathologyPharmacotherapyMetronomic ChemotherapyIneligible Patients	1987	86
Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study. Michael K. Samson, Larry P. Wasser, Ernest C. Borden, Journal of Clinical Oncology Surgical OncologySarcoma Intergroup StudyImidazole CarboxamidePathologyPharmacotherapy	1987	77
Cyclophosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lung. J H Edmonson, Stephen W. Lagakos, Oleg S. Selawry, PubMed Tumor BiologyCell TypesMedicineObjective RegressionPharmacology	1976	73
Prophylactic versus no brain irradiation in regional small cell lung carcinoma H. Gunter Seydel, Richard H. Creech, Michele Pagano, American Journal of Clinical Oncology Adaptive RadiotherapyNeuro-oncologyComplete RespondersRadiation TherapyMedicine	1985	68
Comparison of adriamycin with cyclophosphamide in patients with advanced endometrial cancer. J.J. HORTON, Begg Cb, J Arseneault, PubMed Advanced Endometrial CancerGynecological SurgeryMedicineMetronomic TherapyPharmacology	1978	64

Page 1